Healthcare -
Biotechnology - NASDAQ - US
$ 34.055
1.23 %
$ 14.8 B
Market Cap
17.83
P/E
RPRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities RPRX - Royalty Pharma plc
361 M
LAST VALUE
54.34%
2 YEAR CAGR
18.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR